Asthma, an intermittent disease, is the commonest lung disease in the UK. The second is chronic obstructive pulmonary disease (COPD). This lecture will consider trends and advances in these two diseases, and the chronic genetic lung disease cystic fibrosis.
Lung cancer is the second most common cancer in both men and women, but kills the most people through a combination of being common and currently having much less effective treatment. Both treatment and prevention are currently improving, slowly.
The most common cancer in men in the UK is prostate cancer, around a quarter of all male cancer diagnoses. Testicular cancer, the other male-specific cancer, is rare, but occurs early in life. Neither are preventable.
Different cancers offer differing hopes of prevention; from cervical or lung cancer (which are completely or largely preventable), to prostate cancer (for which there is no current strategy). What can be done, and what does the future hold?
The treatment of cancer has been transformed in the last two decades, and great improvements are expected over the next twenty years. Better genetic understanding and harnessing of the immune system are among the approaches which will make the difference.